Industry: Food & Beverages
Published Date: 2025-03-13
Pages: 95 Pages
Report ld: 4665155
Request Sample
Customized Report
The global Bifidus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
The North America Bifidus market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Bifidus include Chr-Hansen, DuPont, Wecare Probiotics, Probi, Mitushi Bio Pharma, Scitop Bio-tech, Lallemand, Goerlich Pharma, Shandong Zhongke Jiayi Bioengineering, Danone, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Bifidus market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Bifidus market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Pharmaceutical Grade in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Medicines in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Bifidus value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Bifidus Product Scope
1.2 Bifidus by Type
1.2.1 Global Bifidus Sales by Type (2020 & 2024 & 2031)
1.2.2 Food Grade
1.2.3 Pharmaceutical Grade
1.3 Bifidus by Application
1.3.1 Global Bifidus Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Food & Beverages
1.3.3 Medicines
1.3.4 Health Products
1.3.5 Others
1.4 Global Bifidus Market Estimates and Forecasts (2020-2031)
1.4.1 Global Bifidus Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Bifidus Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Bifidus Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Bifidus Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Bifidus Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Bifidus Sales Market Share by Region (2020-2025)
2.2.2 Global Bifidus Revenue Market Share by Region (2020-2025)
2.3 Global Bifidus Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Bifidus Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Bifidus Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Bifidus Market Size and Prospective (2020-2031)
2.4.2 Europe Bifidus Market Size and Prospective (2020-2031)
2.4.3 China Bifidus Market Size and Prospective (2020-2031)
2.4.4 Japan Bifidus Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Bifidus Historic Market Review by Type (2020-2025)
3.1.1 Global Bifidus Sales by Type (2020-2025)
3.1.2 Global Bifidus Revenue by Type (2020-2025)
3.1.3 Global Bifidus Price by Type (2020-2025)
3.2 Global Bifidus Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Bifidus Sales Forecast by Type (2026-2031)
3.2.2 Global Bifidus Revenue Forecast by Type (2026-2031)
3.2.3 Global Bifidus Price Forecast by Type (2026-2031)
3.3 Different Types Bifidus Representative Players
4 Global Market Size by Application
4.1 Global Bifidus Historic Market Review by Application (2020-2025)
4.1.1 Global Bifidus Sales by Application (2020-2025)
4.1.2 Global Bifidus Revenue by Application (2020-2025)
4.1.3 Global Bifidus Price by Application (2020-2025)
4.2 Global Bifidus Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Bifidus Sales Forecast by Application (2026-2031)
4.2.2 Global Bifidus Revenue Forecast by Application (2026-2031)
4.2.3 Global Bifidus Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Bifidus Application
5 Competition Landscape by Players
5.1 Global Bifidus Sales by Players (2020-2025)
5.2 Global Top Bifidus Players by Revenue (2020-2025)
5.3 Global Bifidus Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bifidus as of 2024)
5.4 Global Bifidus Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Bifidus, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Bifidus, Product Type & Application
5.7 Global Key Manufacturers of Bifidus, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Bifidus Sales by Company
6.1.1.1 North America Bifidus Sales by Company (2020-2025)
6.1.1.2 North America Bifidus Revenue by Company (2020-2025)
6.1.2 North America Bifidus Sales Breakdown by Type (2020-2025)
6.1.3 North America Bifidus Sales Breakdown by Application (2020-2025)
6.1.4 North America Bifidus Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Bifidus Sales by Company
6.2.1.1 Europe Bifidus Sales by Company (2020-2025)
6.2.1.2 Europe Bifidus Revenue by Company (2020-2025)
6.2.2 Europe Bifidus Sales Breakdown by Type (2020-2025)
6.2.3 Europe Bifidus Sales Breakdown by Application (2020-2025)
6.2.4 Europe Bifidus Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Bifidus Sales by Company
6.3.1.1 China Bifidus Sales by Company (2020-2025)
6.3.1.2 China Bifidus Revenue by Company (2020-2025)
6.3.2 China Bifidus Sales Breakdown by Type (2020-2025)
6.3.3 China Bifidus Sales Breakdown by Application (2020-2025)
6.3.4 China Bifidus Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Bifidus Sales by Company
6.4.1.1 Japan Bifidus Sales by Company (2020-2025)
6.4.1.2 Japan Bifidus Revenue by Company (2020-2025)
6.4.2 Japan Bifidus Sales Breakdown by Type (2020-2025)
6.4.3 Japan Bifidus Sales Breakdown by Application (2020-2025)
6.4.4 Japan Bifidus Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Chr-Hansen
7.1.1 Chr-Hansen Company Information
7.1.2 Chr-Hansen Business Overview
7.1.3 Chr-Hansen Bifidus Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Chr-Hansen Bifidus Products Offered
7.1.5 Chr-Hansen Recent Development
7.2 DuPont
7.2.1 DuPont Company Information
7.2.2 DuPont Business Overview
7.2.3 DuPont Bifidus Sales, Revenue and Gross Margin (2020-2025)
7.2.4 DuPont Bifidus Products Offered
7.2.5 DuPont Recent Development
7.3 Wecare Probiotics
7.3.1 Wecare Probiotics Company Information
7.3.2 Wecare Probiotics Business Overview
7.3.3 Wecare Probiotics Bifidus Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Wecare Probiotics Bifidus Products Offered
7.3.5 Wecare Probiotics Recent Development
7.4 Probi
7.4.1 Probi Company Information
7.4.2 Probi Business Overview
7.4.3 Probi Bifidus Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Probi Bifidus Products Offered
7.4.5 Probi Recent Development
7.5 Mitushi Bio Pharma
7.5.1 Mitushi Bio Pharma Company Information
7.5.2 Mitushi Bio Pharma Business Overview
7.5.3 Mitushi Bio Pharma Bifidus Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Mitushi Bio Pharma Bifidus Products Offered
7.5.5 Mitushi Bio Pharma Recent Development
7.6 Scitop Bio-tech
7.6.1 Scitop Bio-tech Company Information
7.6.2 Scitop Bio-tech Business Overview
7.6.3 Scitop Bio-tech Bifidus Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Scitop Bio-tech Bifidus Products Offered
7.6.5 Scitop Bio-tech Recent Development
7.7 Lallemand
7.7.1 Lallemand Company Information
7.7.2 Lallemand Business Overview
7.7.3 Lallemand Bifidus Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Lallemand Bifidus Products Offered
7.7.5 Lallemand Recent Development
7.8 Goerlich Pharma
7.8.1 Goerlich Pharma Company Information
7.8.2 Goerlich Pharma Business Overview
7.8.3 Goerlich Pharma Bifidus Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Goerlich Pharma Bifidus Products Offered
7.8.5 Goerlich Pharma Recent Development
7.9 Shandong Zhongke Jiayi Bioengineering
7.9.1 Shandong Zhongke Jiayi Bioengineering Company Information
7.9.2 Shandong Zhongke Jiayi Bioengineering Business Overview
7.9.3 Shandong Zhongke Jiayi Bioengineering Bifidus Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Shandong Zhongke Jiayi Bioengineering Bifidus Products Offered
7.9.5 Shandong Zhongke Jiayi Bioengineering Recent Development
7.10 Danone
7.10.1 Danone Company Information
7.10.2 Danone Business Overview
7.10.3 Danone Bifidus Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Danone Bifidus Products Offered
7.10.5 Danone Recent Development
7.11 Shanghai SPH Sinopharm
7.11.1 Shanghai SPH Sinopharm Company Information
7.11.2 Shanghai SPH Sinopharm Business Overview
7.11.3 Shanghai SPH Sinopharm Bifidus Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Shanghai SPH Sinopharm Bifidus Products Offered
7.11.5 Shanghai SPH Sinopharm Recent Development
8 Bifidus Manufacturing Cost Analysis
8.1 Bifidus Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Bifidus
8.4 Bifidus Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Bifidus Distributors List
9.3 Bifidus Customers
10 Bifidus Market Dynamics
10.1 Bifidus Industry Trends
10.2 Bifidus Market Drivers
10.3 Bifidus Market Challenges
10.4 Bifidus Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Bifidus market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 166
USD 4900.00
(Single User License)
The global Bifidus market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 99
USD 4250.00
(Single User License)
The global market for Bifidus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 111
USD 3950.00
(Single User License)
The global Bifidus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 123
USD 2900.00
(Single User License)
The global Bifidus market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 152
USD 4900.00
(Single User License)
The global market for Bifidus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 119
USD 3950.00
(Single User License)
The global market for Bifidus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-13
Pages: 90
USD 2900.00
(Single User License)
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published Date: 2024-08-02
Pages: 89
USD 2900.00
(Single User License)
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published Date: 2024-08-02
Pages: 157
USD 4900.00
(Single User License)
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published Date: 2024-08-02
Pages: 131
USD 4350.00
(Single User License)
The global Bifidus market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 166
The global Bifidus market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 99
The global market for Bifidus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 111
The global Bifidus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 123
The global Bifidus market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 152
The global market for Bifidus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 119
The global market for Bifidus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-13
Pages: 90
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published: 2024-08-02
Pages: 89
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published: 2024-08-02
Pages: 157
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published: 2024-08-02
Pages: 131
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now